文献速递妇科生殖医学

早期子宫内膜癌保留生育功能治疗达到完全缓解并完成生育后,完成性子宫切除术与未完成性子宫切除术的肿瘤结局比较:妇科肿瘤研究研究者协作研究(GORILLA-3001)

Comparison of oncologic outcomes between completion hysterectomy and no completion hysterectomy in patients who achieved complete response and completed childbearing after fertility-sparing treatment for early-stage endometrial cancer: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-3001).
PubMed 文献 · Gynecol Oncol · 2025-11-13

本研究多中心回顾性比较早期子宫内膜癌患者经孕激素保留生育功能治疗达到完全缓解并完成生育后,行完成性子宫切除术与未行该手术的肿瘤结局。中位随访61.0个月,子宫切除组复发率0%(0/14),非子宫切除组22.4%(13/58),P=0.055。多因素分析显示分娩前复发与妊娠后复发显著相关(HR 3.8,95%CI 1.0-13.3;p<0.05)。作者认为完成性子宫切除术与改善肿瘤结局相关,应考虑对完成生育者行子宫切除术。

要点

  • 中位随访61.0个月,子宫切除组复发率0%(0/14),非子宫切除组22.4%(13/58),P=0.055。
  • 分娩前复发与妊娠后复发显著相关(HR 3.8,95%CI 1.0-13.3;p<0.05)。
  • 作者认为完成性子宫切除术与改善肿瘤结局相关,应考虑对完成生育者行子宫切除术。

核心结论

  • 完成性子宫切除术与保留生育功能治疗后分娩患者的肿瘤结局改善相关,作者认为应考虑对完成生育者行子宫切除术。

研究设计与样本

  • 多中心回顾性研究,纳入2005年至2022年经孕激素保留生育功能治疗达到完全缓解并分娩的疑似IA期、1级子宫内膜样癌患者,比较完成性子宫切除术与未行该手术的肿瘤结局。

主要发现

  • 338例达到完全缓解的患者中,79例(52.7%,79/150)妊娠,包括7例流产和72例活产。
  • 72例分娩患者中14例在分娩后行完成性子宫切除术。
  • 整个队列中位随访61.0个月(范围13-144),复发率子宫切除组0%(0/14) vs 非子宫切除组22.4%(13/58)(P=0.055)。
  • 13例复发患者中8例接受孕激素再治疗,均达到完全缓解;1例在再治疗后第二次活产,随访期间未行完成性子宫切除术被诊断为IVB期宫外疾病。
  • 5例复发后立即行子宫切除术,均无宫外疾病。

临床怎么用

  • 作者认为完成性子宫切除术与改善肿瘤结局相关,应考虑对保留生育功能治疗完成生育的患者行子宫切除术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study evaluated oncological outcomes of completion hysterectomy versus no completion hysterectomy in patients who completed childbearing after achieving complete response (CR) with fertility-sparing treatment (FST) for early-stage endometrial cancer (EC). METHODS: Multicenter data were retrospectively reviewed for patients with presumed stage IA, grade 1 endometrioid EC who gave birth after achieving CR with FST using progestin from 2005 to 2022. Oncologic outcomes were compared between patients who underwent completion hysterectomy and those who did not. RESULTS: Of 338 patients who achieved CR with FST, including those with second or third CR after relapses, 79 (52.7 %, 79/150) became pregnant (seven miscarriages, 72 live births). Completion hysterectomy was performed in 14 of 72 patients after delivery. During a median follow-up time of 61.0 months (range, 13-144) for the entire cohort, recurrence rates were 0 % (0/14) in the hysterectomy group and 22.4 % (13/58) in the non-hysterectomy group (P = 0.055). Progestin re-treatment was administered to 8 of 13 patients who relapsed, and CR was achieved in all. One patient, after a second live birth following re-treatment, was diagnosed with stage IVB extra-uterine disease during follow-up without completion hysterectomy. Five patients underwent hysterectomy immediately after recurrence, and none had extra-uterine disease. In multivariate analysis, recurrence before childbirth (HR 3.8, 95 % CI 1.0-13.3; p < 0.05) was significantly associated with recurrence after pregnancy. CONCLUSION: Completion hysterectomy is associated with improved oncologic outcomes in patients who deliver after FST. Therefore, hysterectomy should be considered for patients who have completed childbearing after FST.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Lee AJ, Jang EB, Suh DH, et al. Comparison of oncologic outcomes between completion hysterectomy and no completion hysterectomy in patients who achieved complete response and completed childbearing after fertility-sparing treatment for early-stage endometrial cancer: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-3001). Gynecol Oncol. 2025. PMID: 41237702. doi:10.1016/j.ygyno.2025.10.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。